Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $154.49M | $166.51M | 59.08% | +$12.01M |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 1,115,352 | 0 | $32.09M | $51.80M | 18.38% | +$19.71M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $19.73M | $13.55M | 4.81% | -$6.18M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $7.80M | $10.22M | 3.63% | +$2.41M |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | $2.98M | $10.02M | 3.55% | +$7.03M |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $14.49M | $9.91M | 3.52% | -$4.58M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $5.82M | $6.76M | 2.40% | +$940.2K |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 964,500 | 0 | $6.08M | $3.65M | 1.29% | -$2.43M |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $8.07M | $3.10M | 1.10% | -$4.97M |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $2.31M | $1.84M | 0.65% | -$463.8K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $1.70M | $1.59M | 0.56% | -$113.4K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $499.6K | $1.08M | 0.38% | +$577.8K |
| Marker Therapeutics, Inc.(MRKR) | 314,286 | 325,370 | +11,084 | $886.3K | $1.01M | 0.36% | +$125.6K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 88,607 | +88,607 | $0 | $762.0K | 0.27% | +$762.0K |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | $66.4K | $46.2K | 0.02% | -$20.2K |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 0 | -886,075 | $1.51M | $0 | — | -$1.51M |
| Tectonic Therapeutic, Inc.(TECX) | 84,148 | 0 | -84,148 | $2.55M | $0 | — | -$2.55M |